ResMed
Stock Forecast, Prediction & Price Target

ResMed (RMD) stock Price Target by analysts

Last Year
Average Price Target

$233.5

Potential downside: -17.69%

Based on 4 analysts

ResMed price prediction

Strike.market

What is ResMed stock analysts` prediction?

ResMed stock forecast: Based on 4 Wall Street analysts` predicted price targets for ResMed in the last 3 months, the avarage price target is $233.5, with a high forecast of $NaN. The average price target represents a -17.69% change from the last price of $283.7.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

ResMed stock Price Target by analysts

Full breakdown of analysts given ResMed price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Jonathan Block
Stifel Nicolaus
0%
0/1
9 months ago $250 -11.87% downside $242.51 TheFly
Previous targets (0)
Craig Wong-Pan
RBC Capital
33.33%
1/3
11 months ago $224 -21.04% downside $238.95 StreetInsider
Previous targets (2)
Joe Vruwink
Robert W. Baird
0%
0/1
11 months ago $280 -1.30% downside $246.18 StreetInsider
Previous targets (0)
Mike Polark
Wolfe Research
0%
0/1
12 months ago $180 -36.55% downside $250.88 StreetInsider
Previous targets (0)
Craig Wong-Pan
RBC Capital
33.33%
1/3
over 1 year ago $187 -34.08% downside $194.27 StreetInsider
Previous targets (2)
Mike Matson
Stifel Nicolaus
0%
0/1
over 1 year ago $224 -21.04% downside $198.03 StreetInsider
Previous targets (0)
Suraj Kalia
Oppenheimer
50%
1/2
almost 2 years ago $175 -38.31% downside $134.65 Benzinga
Previous targets (1)
Mike Matson
Needham
100%
1/1
almost 2 years ago $180 -36.55% downside $153.89 StreetInsider
Previous targets (0)
Craig Wong-Pan
RBC Capital
33.33%
1/3
about 3 years ago $244 -13.99% downside $197.57 Pulse 2.0
Previous targets (2)
Suraj Kalia
Oppenheimer
50%
1/2
almost 4 years ago $312 9.97% upside $253.77 StreetInsider
Previous targets (1)
Sean Laaman
Morgan Stanley
100%
1/1
about 4 years ago $250 -11.87% downside $271.87 StreetInsider
Previous targets (0)
Anthony Petrone
Jefferies
100%
1/1
about 4 years ago $240 -15.40% downside $264.75 TheFly
Previous targets (0)

ResMed Financial Estimates

ResMed Revenue Estimates

ResMed EBITDA Estimates

ResMed Earnings per Share Estimates

Passed Analyst forecast
Metric 6/30/2022 6/30/2023 6/30/2024 6/30/2026 6/30/2027 6/30/2028
Revenue
 
% change YoY
$3.57B
 
N/A
$4.22B
 
18.02%
$4.68B
 
10.94%
Avg: $5.35B
Low: $5.23B
High: $5.46B
avg. 14.24%
Avg: $5.69B
Low: $5.57B
High: $5.82B
avg. 6.42%
Avg: $6.14B
Low: $6.01B
High: $6.28B
avg. 7.96%
Net Income
 
% change YoY
$779.43M
 
N/A
$897.55M
 
15.15%
$1.02B
 
13.74%
Avg: $1.37B
Low: $1.20B
High: $1.49B
avg. 34.94%
Avg: $1.50B
Low: $1.46B
High: $1.54B
avg. 9.09%
Avg: $1.54B
Low: $1.50B
High: $1.59B
avg. 3.00%
EBITDA
 
% change YoY
$1.19B
 
N/A
$1.35B
 
13.79%
$1.53B
 
12.86%
Avg: $1.77B
Low: $1.73B
High: $1.81B
avg. 15.68%
Avg: $1.88B
Low: $1.84B
High: $1.92B
avg. 6.42%
Avg: $2.03B
Low: $1.99B
High: $2.08B
avg. 7.96%
EPS
 
% change YoY
$5.34
 
N/A
$6.12
 
14.60%
$6.94
 
13.39%
Avg: $9.16
Low: $8.16
High: $10.14
avg. 32.03%
Avg: $10.19
Low: $9.91
High: $10.48
avg. 11.24%
Avg: $10.5
Low: $10.2
High: $10.8
avg. 3.00%
Operating Expenses
 
% change YoY
$1.02B
 
N/A
$1.20B
 
17.54%
$1.33B
 
10.94%
Avg: $1.17B
Low: $1.15B
High: $1.20B
avg. -11.85%
Avg: $1.25B
Low: $1.22B
High: $1.28B
avg. 6.42%
Avg: $1.35B
Low: $1.32B
High: $1.38B
avg. 7.96%

FAQ

What is ResMed stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 15.68% in 2026-2028.

We have gathered data from 9 analysts. Their low estimate is 1.20B, average is 1.37B and high is 1.49B.

What is ResMed stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 9.54% in 2026-2028.

We have gathered data from 19 analysts. Their low revenue estimate is $5.23B, average is $5.35B and high is $5.46B.

What is ResMed stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 15.42% in 2026-2028.

We have gathered data from 9 analysts. Their low earnings per share estimate is $8.16, average is $9.16 and high is $10.14.

What is the best performing analyst?

In the last twelve months 4 analysts have been covering ResMed stock. The most successful analyst is Jonathan Block.